AK002, a Novel Humanized Monoclonal Antibody to Siglec-8, Inhibits Mast Cell Activity and Depletes Eosinophils in Ex Vivo Bone Marrow Tissue from Patients with Systemic Mastocytosis
Bradford A. Youngblood(Allakos (United States)), Nenad Tomašević(Regenxbio (United States)), Emily C. Brock(Allakos (United States)), John Leung(Tufts University), Alan T. Chang(Allakos (United States)), Christopher Bebbington(Curtin University)
Cited by 4
Related Papers
Chimeric Receptors Providing Both Primary and Costimulatory Signaling in T Cells from a Single Gene Product
|The Journal of Immunology|1998|546
Symptoms Have Modest Accuracy in Detecting Endoscopic and Histologic Remission in Adults With Eosinophilic Esophagitis
|Gastroenterology|2015|328
Anti–Siglec-8 Antibody for Eosinophilic Gastritis and Duodenitis
|New England Journal of Medicine|2020|263
Budesonide Oral Suspension Improves Symptomatic, Endoscopic, and Histologic Parameters Compared With Placebo in Patients With Eosinophilic Esophagitis
|Gastroenterology|2016|228
International Consensus Recommendations for Eosinophilic Gastrointestinal Disease Nomenclature
|Clinical Gastroenterology and Hepatology|2022|175